Login to Your Account

A Sign of IPOs to Come?

Clovis Prices Within Range; Adds $130M for Cancer Trials

By Jennifer Boggs
Managing Editor

Thursday, November 17, 2011
Clovis Oncology Inc., a small, development-stage firm based in Boulder, Colo., has done what no other biotech has managed this year: priced its initial public offering (IPO) actually within its initial range.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription